Cargando…
Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate) in rats.
Ethyl-alpha-p-chlorophenoxyisobutyrate), a hypolipidaemic drug which induces hepatomegaly and proliferation of peroxisomes in liver cells of rats and mice, was fed to 15 male F344 rats at a dietary concentration of 0.5% (v/w) for up to 28 months. Hepatocellular carcinomas developed in 10/11 (91%) ra...
Autores principales: | Reddy, J. K., Qureshi, S. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1979
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010046/ https://www.ncbi.nlm.nih.gov/pubmed/508572 |
Ejemplares similares
-
RESPONSE OF HEPATIC MICROBODIES TO A HYPOLIPIDEMIC AGENT, ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB)
por: Svoboda, Donald J., et al.
Publicado: (1966) -
Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer
por: Chandran, Karthic, et al.
Publicado: (2015) -
Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound.
por: Rao, M. S., et al.
Publicado: (1988) -
Transplacental induction of fatty acid oxidation in term fetal pigs by the peroxisome proliferator-activated receptor alpha agonist clofibrate
por: Lin, Xi, et al.
Publicado: (2015) -
Clofibrate treatment in pigs: Effects on parameters critical with respect to peroxisome proliferator-induced hepatocarcinogenesis in rodents
por: Luci, Sebastian, et al.
Publicado: (2007)